Healthcare and Life Science
The inaugural Cambridge Independent Business Awards are now open for entry
Cambridge Independent are pleased to announce the launch of the inaugural Cambridge Independent Business Awards. A celebration of all business sectors in the Cambridge region, the awards will culminate in a gala event in the magnificent Great Hall at King’s College on 26 September. ...
Illumina launches latest chemistry across most popular mid-throughput sequencers, enabling higher quality and greater speed for customers at lower cost
SAN DIEGO - PRNewswire -- Illumina Inc., a global leader in DNA sequencing and array-based technologies, announces it has completed integration of its latest chemistry, XLEAP-SBS™, into all reagents for its NextSeq™ 1000 and NextSeq 2000 next-generation sequencing (NGS) instruments. ...
Experts launch team effort to help patient Alex
The fifth episode of The Face Doctors on Really, shown at 9pm on Wednesday (12 June) tells the story of a patient who became a prisoner in his own home after his entire nose was lost to cancer. ...
Politics in the workplace
By the HR Dept.
Nuclera awarded £1.14M Innovate UK funding for development of eProtein Discovery
£790k FASST grant, in collaboration with DeepMirror, and £350k Engineering Biology grant awarded for platform development. ...
MediMab Biotherapeutics opens bespoke laboratory facilities, created by Kadans Science Partner, at Abingdon Science Park, UK
New CL2 wet lab purpose-built facilities delivered by Kadans Science Partner will support MediMab Biotherapeutics to identify first-in-class immuno-oncology drugs that can actively target a range of advanced and solid tumours Kadans has also completed on Barton House, a new research...
o2h Group heralds massive demand for Cambridge Wide Open Day
Attendance levels for the 2024 Cambridge Wide Open Day on Wednesday June 12 are already double the numbers at last year’s inaugural event. o2h Group, which is organising the event, has persuaded some world-class life science and technology companies plus relevant associated organisation...
Time from EMA approval to CT outcome for first indication vs. AMSR
This post launches a series of infographics focused on pricing and market access trends of rare disease treatments in France. Each post in this series zooms into a specific PMA trend by leveraging RADAR, CRA’s orphan drug data repository that includes all orphan drugs granted EMA approv...
Impact of medicare price “negotiation” program on small and large molecule medicines
The Inflation Reduction Act (IRA) directs the U.S. federal government to set a “Maximum Fair Price” (MFP) for the medicines with the highest spending in Medicare. The MFP will be implemented for selected small molecule drugs as early as nine years after approval, and as early as 13 year...
VALANX Biotech announces promising results in first in-vivo study of novel protein conjugate therapy
Study demonstrates pre-clinical efficacy of lead program VLX101 in treating autoimmune disease ...